Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.38 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.38 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL215965 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL997389 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL997391 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL3505233 | 1.00 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL14094312 | 0.92 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL16048661 | 0.92 | PTPN1 (0.58) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL31412851 | 0.89 | PTPN1 (0.55) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL16166818 | 0.89 | PTPN1 (0.55) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL25341538 | 0.88 | ALOX15 (0.61) | PTPN1ALOX15BLMLMNAALDH1A1 | |
| SCHEMBL7552905 | 0.87 | ALOX15 (0.70) | PTPN1ALOX15LMNAALDH1A1CHRM5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 151 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024115594-A1 | ACETIC ACID FOR INTENSIFYING OR MODIFYING THE AROMA OF AROMA CHEMICALS | BASF SE (DE) | 2024-06-06 | — | — | WO | claimed |
| CN-106999893-B | Method for encapsulating active substances in droplets and other compartments | 宝洁公司 | 2020-07-14 | — | — | CN | claimed |
| CN-106999361-B | Compositions comprising encapsulated actives in droplets and other compartments | 宝洁公司 | 2019-12-24 | — | — | CN | claimed |
| US-9200298-B2 | Host cells and methods for producing isoprenyl alkanoates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2015-12-01 | — | — | US | claimed |
| US-20100180491-A1 | Host Cells and Methods for Producing Isoprenyl Alkanoates | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2010-07-22 | — | — | US | claimed |
| WO-2009006386-A2 | HOST CELLS AND METHODS FOR PRODUCING ISOPRENYL ALKANOATES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-01-08 | — | — | WO | claimed |
| US-6844302-B1 | Encapsulated flavor and fragrance | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 2005-01-18 | — | — | US | claimed |
| EP-4727515-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-04-22 | — | — | EP | disclosed |
| EP-3578161-B1 | METHOD FOR IMPROVING STORAGE STABILITY OF COSMETIC | ADEKA CORP (JP) | 2025-11-12 | — | — | EP | disclosed |
| EP-4593787-A1 | ALCOHOL-FREE FRAGRANCE COMPOSITION | ITC Life Sciences & Technology Centre (IN) | 2025-08-06 | — | — | EP | disclosed |
| WO-2025126062-A1 | ALCOHOL-FREE FRAGRANCE COMPOSITION | ITC LIFE SCIENCES & TECHNOLOGY CENTRE (IN) | 2025-06-19 | — | — | WO | disclosed |
| WO-2024256539-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-12-19 | — | — | WO | disclosed |
| US-20240400471-A1 | LABELING METHOD, OXIDANT FOR LABELING, RUTHENIUM COMPLEX, CATALYST, LABELING COMPOUND, AND COMPOUND | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2024-12-05 | — | — | US | disclosed |
| WO-1999026601-A1 | NITRILE PERFUMERY MATERIAL | BUSH BOAKE ALLEN INC. (US) | 1999-06-03 | — | — | WO | disclosed |
| US-5888962-A | CONTAINING 3-METHYL-5-(PHENYL OR CYCLOHEXYL)-PENTANENITRILE | BUSH BOAKE ALLEN INC. (US) | 1999-03-30 | — | — | US | disclosed |
| EP-0545556-B1 | Perfume composition | QUEST INT (NL) | 1997-07-23 | — | — | EP | disclosed |
| US-5554588-A | IN WHICH AT LEAST HALF COMPRISES ETHERS, AROMATIC METHYL KETONES, ALCOHOLS, ESTERS AND SALICYLATES; DEODORANTS AND ACCEPTABLE FRAGRANCE | LEVER BROTHERS COMPANY, DIVISION OF CONOPCO, INC. (US) | 1996-09-10 | — | — | US | disclosed |
| US-5482635-A | Fabric conditioner with deodorant perfume composition | LEVER BROTHERS COMPANY (US) | 1996-01-09 | — | — | US | disclosed |
| EP-0684037-A1 | Deodorant compositions | UNILEVER PLC (GB) | 1995-11-29 | — | — | EP | disclosed |
| EP-0545556-A2 | Perfume composition | QUEST INTERNATIONAL NEDERLAND BV (NL) | 1993-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240400471-A1 | LABELING METHOD, OXIDANT FOR LABELING, RUTHENIUM COMPLEX, CATALYST, LABELING COMPOUND, AND COMPOUND | HAO2, LPO, HAO1 | PTPN1 4579/4885ALOX15 295/4885BLM 2990/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.